Friday 6 November 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue: +7.64%
EPS: −12.4%
Free cash flow: −19.4%
Total debt: −10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%

Follow SYK

Alert me

Market cap: $127.6B
P/E: 35.3×
Fwd P/E: 24.6×
Dividend yield: 1.05%
F-score: 5/9
Altman Z: 4.81
Beneish M: −2.62
Dividend safety: 82/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Stryker Corporation 10-Q filed Oct 31, 2025

Fiscal Q3 2025 · Period ended Sep 30, 2025 · Filed Oct 31, 2025 · accepted 10:39 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Aug 1, 2025: no changes